Nicholas A. Peppas

6.6k total citations · 3 hit papers
44 papers, 5.3k citations indexed

About

Nicholas A. Peppas is a scholar working on Biomaterials, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Nicholas A. Peppas has authored 44 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomaterials, 15 papers in Molecular Biology and 12 papers in Molecular Medicine. Recurrent topics in Nicholas A. Peppas's work include Nanoparticle-Based Drug Delivery (16 papers), Hydrogels: synthesis, properties, applications (12 papers) and RNA Interference and Gene Delivery (11 papers). Nicholas A. Peppas is often cited by papers focused on Nanoparticle-Based Drug Delivery (16 papers), Hydrogels: synthesis, properties, applications (12 papers) and RNA Interference and Gene Delivery (11 papers). Nicholas A. Peppas collaborates with scholars based in United States, Italy and Spain. Nicholas A. Peppas's co-authors include Mary Caldorera‐Moore, Stephanie D. Steichen, Mar Creixell, Angela M. Wagner, Gorka Orive, Jennifer M. Knipe, Robert Gurny, Éric Doelker, Ronald S. Harland and Nikhil J. Kavimandan and has published in prestigious journals such as ACS Nano, Biomaterials and Advanced Functional Materials.

In The Last Decade

Nicholas A. Peppas

42 papers receiving 5.1k citations

Hit Papers

Opsonization, biodistribu... 2005 2026 2012 2019 2005 2012 2019 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas A. Peppas United States 23 2.9k 1.9k 1.9k 977 890 44 5.3k
Chunhua Yin China 39 2.5k 0.9× 1.6k 0.8× 2.4k 1.3× 1.4k 1.4× 651 0.7× 87 5.8k
Juliana M. Chan United States 17 3.0k 1.0× 2.3k 1.2× 2.3k 1.2× 823 0.8× 1.0k 1.2× 21 5.9k
Zhonggao Gao China 38 2.7k 0.9× 2.4k 1.2× 2.2k 1.2× 835 0.9× 821 0.9× 121 5.9k
Mary E. Napier United States 27 2.6k 0.9× 2.2k 1.2× 2.1k 1.1× 507 0.5× 1.2k 1.4× 48 5.5k
Paolo Caliceti Italy 41 2.2k 0.8× 1.5k 0.8× 2.4k 1.3× 978 1.0× 646 0.7× 168 6.6k
Catherine Dubernet France 33 4.0k 1.4× 2.6k 1.4× 2.5k 1.3× 1.2k 1.3× 1.4k 1.6× 64 7.4k
Gaetano Giammona Italy 40 2.1k 0.7× 1.5k 0.8× 1.1k 0.6× 967 1.0× 900 1.0× 201 5.1k
Youngro Byun South Korea 49 2.1k 0.8× 1.6k 0.8× 3.2k 1.7× 1.2k 1.2× 464 0.5× 261 7.8k
Soon Hong Yuk South Korea 40 1.8k 0.6× 1.7k 0.9× 931 0.5× 949 1.0× 723 0.8× 108 4.8k
Catherine Passirani France 39 2.5k 0.9× 1.4k 0.7× 2.5k 1.4× 845 0.9× 444 0.5× 89 5.5k

Countries citing papers authored by Nicholas A. Peppas

Since Specialization
Citations

This map shows the geographic impact of Nicholas A. Peppas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas A. Peppas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas A. Peppas more than expected).

Fields of papers citing papers by Nicholas A. Peppas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas A. Peppas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas A. Peppas. The network helps show where Nicholas A. Peppas may publish in the future.

Co-authorship network of co-authors of Nicholas A. Peppas

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas A. Peppas. A scholar is included among the top collaborators of Nicholas A. Peppas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas A. Peppas. Nicholas A. Peppas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richbourg, Nathan, et al.. (2025). Network theory and recent developments in networks formed by the freeze–thawing process. Polymer. 344. 129385–129385.
2.
Wagner, Angela M., et al.. (2025). Rational Design of PEGylated Nanogels: Optimization of Degree of PEGylation and Development of a Novel Enzyme-Responsive Grafted Layer. International Journal of Pharmaceutics. 684. 126102–126102.
3.
Malik, K.M.A., et al.. (2024). The role of patient-specific variables in protein corona formation and therapeutic efficacy in nanomedicine. Journal of Nanobiotechnology. 22(1). 714–714. 14 indexed citations
4.
Arnspang, Eva C., et al.. (2023). SiRNA Delivery Mediated by pH and Redox Responsive P(DEAEMA-Co-HEMA-G-PEGMA) Nanogels. SSRN Electronic Journal. 3 indexed citations
5.
Lanier, Olivia L., et al.. (2023). siRNA delivery from cationic nanocarriers prepared by diffusion‐assisted loading in the presence and absence of electrostatic interactions. Journal of Applied Polymer Science. 141(9). 1 indexed citations
6.
Spencer, David S., et al.. (2021). Cytocompatibility, membrane disruption, and siRNA delivery using environmentally responsive cationic nanogels. Journal of Controlled Release. 332. 608–619. 21 indexed citations
7.
Murphy, Andrew C., et al.. (2020). Recent Advances in Smart Biomaterials for the Detection and Treatment of Autoimmune Diseases. Advanced Functional Materials. 30(37). 21 indexed citations
8.
Wagner, Angela M., Jennifer M. Knipe, Gorka Orive, & Nicholas A. Peppas. (2019). Quantum dots in biomedical applications. Acta Biomaterialia. 94. 44–63. 379 indexed citations breakdown →
9.
Peppas, Nicholas A., et al.. (2014). Polycationic Nanoparticles for siRNA Delivery: Comparing ARGET ATRP and UV-Initiated Formulations. ACS Nano. 8(3). 2908–2917. 47 indexed citations
10.
Creixell, Mar, et al.. (2013). Polycationic nanoparticles synthesized using ARGET ATRP for drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 84(3). 472–478. 29 indexed citations
11.
Steichen, Stephanie D., Mary Caldorera‐Moore, & Nicholas A. Peppas. (2012). A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. European Journal of Pharmaceutical Sciences. 48(3). 416–427. 591 indexed citations breakdown →
12.
Creixell, Mar & Nicholas A. Peppas. (2012). Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance. Nano Today. 7(4). 367–379. 277 indexed citations
13.
Hilt, J. Zach, et al.. (2007). Nanotechnology in therapeutics : current technology and applications. 41 indexed citations
14.
Kavimandan, Nikhil J., E. Losi, & Nicholas A. Peppas. (2006). Novel delivery system based on complexation hydrogels as delivery vehicles for insulin–transferrin conjugates. Biomaterials. 27(20). 3846–3854. 71 indexed citations
15.
Mallapragada, Surya K. & Nicholas A. Peppas. (1997). Crystal unfolding and chain disentanglement during semicrystalline polymer dissolution. AIChE Journal. 43(4). 870–876. 39 indexed citations
16.
Peppas, Nicholas A. & Paolo Colombo. (1989). Development of disintegration forces during water penetration in porous pharmaceutical systems. Journal of Controlled Release. 10(3). 245–250. 29 indexed citations
17.
Peppas, Nicholas A.. (1986). Surface and interfacial aspects of biomedical polymers. Vol. 2, protein adsorption. Biomaterials. 7(4). 310–310. 79 indexed citations
18.
Peppas, Nicholas A.. (1986). Macromolecules, vol. 2, synthesis, materials and technology. Journal of Controlled Release. 3(1-4). 212–213. 2 indexed citations
19.
Peppas, Nicholas A.. (1984). Wissenschaftliche tabellen Geigy (Scientific tables Geigy). Journal of Controlled Release. 1(1). 83–83. 1 indexed citations
20.
Gurny, Robert, Éric Doelker, & Nicholas A. Peppas. (1982). Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers. Biomaterials. 3(1). 27–32. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026